Short Interest in InterCure Ltd. (NASDAQ:INCR) Grows By 24.5%

InterCure Ltd. (NASDAQ:INCR) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 34,100 shares, an increase of 24.5% from the March 15th total of 27,400 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average daily volume of 20,800 shares, the short-interest ratio is presently 1.6 days.

Institutional Trading of InterCure

Several institutional investors have recently added to or reduced their stakes in the stock. Moore Capital Management LP acquired a new stake in shares of InterCure during the fourth quarter worth $156,000. Jane Street Group LLC bought a new position in shares of InterCure in the 3rd quarter worth about $49,000. Finally, Virtu Financial LLC bought a new stake in shares of InterCure during the 3rd quarter valued at about $43,000. 8.34% of the stock is currently owned by institutional investors.

InterCure Price Performance

NASDAQ:INCR traded down $0.03 during trading hours on Monday, hitting $1.35. 5,126 shares of the company were exchanged, compared to its average volume of 34,771. The company has a fifty day simple moving average of $1.49 and a 200 day simple moving average of $1.56. InterCure has a one year low of $1.17 and a one year high of $3.72. The company has a quick ratio of 1.15, a current ratio of 1.78 and a debt-to-equity ratio of 0.15.

InterCure Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.